2gmi: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2gmi.jpg|left|200px]]
{{Seed}}
[[Image:2gmi.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2gmi|  PDB=2gmi  |  SCENE=  }}  
{{STRUCTURE_2gmi|  PDB=2gmi  |  SCENE=  }}  


'''Mms2/Ubc13~Ubiquitin'''
===Mms2/Ubc13~Ubiquitin===




==Overview==
<!--  
Lys63-linked polyubiquitin chains participate in nonproteolytic signaling pathways, including regulation of DNA damage tolerance and NF-kappaB activation. E2 enzymes bound to ubiquitin E2 variants (UEV) are vital in these pathways, synthesizing Lys63-linked polyubiquitin chains, but how these complexes achieve specificity for a particular lysine linkage has been unclear. We have determined the crystal structure of an Mms2-Ubc13-ubiquitin (UEV-E2-Ub) covalent intermediate with donor ubiquitin linked to the active site residue of Ubc13. In the structure, the unexpected binding of a donor ubiquitin of one Mms2-Ubc13-Ub complex to the acceptor-binding site of Mms2-Ubc13 in an adjacent complex allows us to visualize at atomic resolution the molecular determinants of acceptor-ubiquitin binding. The structure reveals the key role of Mms2 in allowing selective insertion of Lys63 into the Ubc13 active site and suggests a molecular model for polyubiquitin chain elongation.
The line below this paragraph, {{ABSTRACT_PUBMED_16980971}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16980971 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16980971}}


==About this Structure==
==About this Structure==
Line 35: Line 39:
[[Category: Ubiquitin]]
[[Category: Ubiquitin]]
[[Category: Uev]]
[[Category: Uev]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 05:16:20 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 12:54:57 2008''